Senior Director
Pfizer, Inc.
Disclosure(s): Pfizer Inc: employee, Stocks/Bonds (Private Company)
Reiko Sato, Ph.D. is Senior Director for the vaccines therapeutic area in the Value & Evidence group within Pfizer, based in Collegeville, Pennsylvania, US. Reiko has devoted the past 10+ years documenting the burden of vaccine-preventable diseases from a payer and patient perspectives, as well as laying the groundwork to estimate the potential public health and economic impact of vaccines in adults. Her work experience within outcomes research has been diverse and includes the design and conduct of prospective and retrospective observational studies, development of economic models, training on use and interpretation of epidemiologic and economic data, quality improvement programs, patient-reported outcomes analytics and reporting, and the development of evidence dossiers. She has co-authored numerous publications, many on the economic and humanistic value of Pfizer products in the area of vaccine, rheumatology, dermatology, and transplantation. Reiko received her Ph.D. in epidemiology from the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, USA and a BA from Oberlin College. In her spare time, you will find Reiko enjoying cooking, attending visual and performing art events, and the great outdoors.